Evicenter
P&T meetings

Zipalertinib (CLN-081)

EGFR exon 20 insertion-mutated non-small-cell lung cancer

Also known as TAS6417
Manufacturer
Taiho Oncology
Regulatory submission
NDA submitted February 2026
Launch
Not announced
Last updated
75 sources

Product information and disease descriptionProduct descriptionProduct information

Dosage forms and strengths

3 evidence topics · 3 sources

Commercial dosage forms, strengths, storage, and handling

No evidence found.

Research reagent safety data sheet
SDS information elementDirect quotation
Product name“Zipalertinib”
Product catalogue number“207108”
CAS number“1661854-97-2”
Identified uses“Laboratory chemicals, Synthesis of substances.”
Revision date“5/20/2022”